BMO Capital upgraded Goeasy (EHMEF) to Outperform from Market Perform with a price target of C$200, down from C$207. Goeasy trades at trough multiples on tariff-scenario earnings, effectively ...

On Thursday, BMO Capital Markets sustained their Market Perform rating on Casey’s General Stores (NASDAQ:CASY), with a steady price target of $450.00. The convenience store chain, currently ...

BMO Capital analyst Kostas Biliouris initiated ... Duchenne muscular dystrophy and myotonic dystrophy type 1. The DM1 market is large enough to accommodate multiple players, and Dyne could ...

Shares of NYSE:STEM opened at $0.44 on Wednesday. The firm has a market cap of $72.10 million, a price-to-earnings ratio of -0.09 and a beta of 1.49. Stem has a 12 month low of $0.30 and a 12 ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...

Ecolab (NYSE:ECL – Get Free Report) had its target price raised by stock analysts at BMO Capital Markets from $295.00 to $305.00 in a report released on Monday,Benzinga reports. The firm ...

(Bloomberg) -- Bank of Montreal and Bank of Nova Scotia kicked off Canadian bank earnings season with strong results from their capital-markets divisions amid an increase in trading activity.

On Thursday, BMO Capital Markets sustained their Market Perform rating on Casey’s General Stores (NASDAQ:CASY), with a steady price target of $450.00. The convenience store chain, currently valued at ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of $12 ...

On Tuesday, BMO Capital Markets began coverage of Avidity Biosciences (NASDAQ:RNA) shares, assigning an Outperform rating and setting a price target of $72.00. Currently trading at $29.58, the stock ...